PRMT2 and cancer: Here, we show that long-term treatment with the antiandrogen FLU activates Sirt1 and decreases the expression of PRMT2, suggesting that LN-FLU cells may undergo specific epigenetic changes that enable them to enter a dormant state and persist in a non-proliferative state that contribute to the ability of cancer cells to evade therapies.